nimodipine has been researched along with Lymphocytosis in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Lymphocytosis: Excess of normal lymphocytes in the blood or in any effusion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fiamingo, G | 1 |
| Canavero, I | 1 |
| Gastaldi, M | 1 |
| Coloberti, E | 1 |
| Buongarzone, G | 1 |
| Ghiotto, N | 1 |
| Bacila, A | 1 |
| Costa, A | 1 |
| Ravaglia, S | 1 |
1 review available for nimodipine and Lymphocytosis
| Article | Year |
|---|---|
HaNDL syndrome: a reversible cerebral vasoconstriction triggered by an infection? A case report and a case-based review.
Topics: Adult; Albumins; Calcium Channel Blockers; Epstein-Barr Virus Nuclear Antigens; Headache; Humans; Im | 2022 |